AZD9668 + AZD9668 Placebo equivalent
Phase 2Completed 0 watching 0 views this week⚡ Active
52
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Cystic Fibrosis
Conditions
Cystic Fibrosis
Trial Timeline
Oct 1, 2008 → Aug 1, 2009
NCT ID
NCT00757848About AZD9668 + AZD9668 Placebo equivalent
AZD9668 + AZD9668 Placebo equivalent is a phase 2 stage product being developed by AstraZeneca for Cystic Fibrosis. The current trial status is completed. This product is registered under clinical trial identifier NCT00757848. Target conditions include Cystic Fibrosis.
Hype Score Breakdown
Clinical
17
Activity
12
Company
10
Novelty
5
Community
5
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00757848 | Phase 2 | Completed |
Competing Products
20 competing products in Cystic Fibrosis